Our purpose is to disrupt disease transmission. At Varro Life Sciences, we develop innovative products and technologies that make a global impact across economic and cultural borders. We are ambitious and dedicated in our pursuit to leverage technology that saves lives, ensures safe environments, and prevents future pandemics. The company was established in January 2020 as Y2X Life Sciences, and the company name was changed in October 2024.
| Website | https://varrobio.com/ |
| Employees | 19 (14 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Life Sciences, Health Technology, Medical Technology, Innovative Products, Medical Innovation, Biomedical Engineering, Global Impact, Disease Control, Disease Prevention, Infectious Disease, Health Solutions, Public Health, Epidemic Control, Pharmaceutical Research, Pandemic Preparedness, Scientific Research, Drug Discovery |
| Competitors | Novartis, Regeneron, Drexel University, Beam Therapeutics, Intellia Therapeutics, Inc., CRISPR Therapeutics, bluebird bio, Editas Medicine, Sangamo Therapeutics, Inc., Cellectis +36 more (view full list) |
Looking for a particular Varro employee's phone or email?
Tom Cirrito is the CEO, Co-Founder and Chairman of Board of Varro.
14 people are employed at Varro.
Varro is based in St. Louis, Missouri.